Shares of PPL Corp. PPL slid 1.98% to $33.73 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 0.01% to 6,114.63 and Dow Jones ...
Zacks.com on MSN21h
All You Need to Know About PLIANT THERAPT (PLRX) Rating Upgrade to BuyPliant Therapeutics, Inc. (PLRX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates ...
PPL Corporation (NYSE:PPL), a leading energy company, disclosed on Thursday the establishment of an Equity Distribution Agreement and Master Forward Confirmations that could facilitate the sale of up ...
We estimate that PPL will invest $23 billion at its utilities through 2028. This will require PPL to issue debt to maintain its current capital structure. With management's uptick in capital ...
Pliant Therapeutics (PLRX) stock jumped 21% Thursday after the company issued an update for a Phase 2b clinical study of ...
PPL has raised its quarterly dividend by 5.8%, to 27.25 cents from 25.75 cents, and boosted its capital-spending plan. The new payout, equal to $1.09 a year, represents an annual yield of about 3.16%, ...
PPL Corp. (PPL) increased its quarterly common stock dividend 6% raising the dividend from 25.75c per share to 27.25c per share. The dividend ...
Shares of Palantir Technologies ( PLTR 1.06%) have been one of the best-performing artificial intelligence (AI) stocks over the past few years. Another blowout earnings report sent the stock surging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback